Cited by 54Schizophrenia research and treatmentSexual function and dysfunction studiesSexuality, Behavior, and Technology

Sexual dysfunction in schizophrenia

Malik, Peter·2007·Current Opinion in Psychiatry

Abstract

PURPOSE OF REVIEW: Sexual dysfunctions have been described as being common in schizophrenia patients. The pathophysiology behind their development remains unclear. They can be secondary to the disease itself or an adverse event of antipsychotic medication. Therapeutic interventions are also not well studied. RECENT FINDINGS: Earlier work has suggested that second-generation antipsychotics bear fewer risks for developing sexual dysfunction because of a lower propensity to elevate prolactin levels, although the latter does not apply to amisulpride and risperidone. Only a few controlled trials with larger patient samples have been performed in the past. SUMMARY: The review covers studies published from March 2005 to June 2006 focusing on sexual dysfunctions in schizophrenia patients, as well as their possible causes. Treatment options and the impact of sexual dysfunction on quality of life are also covered. The reviewed papers show no clear consistency regarding potential advantages of one drug over another. Many trials suffer from small sample sizes. The field badly needs more and larger studies on this topic.

Integrity signals

Registry

Crossref · 10.1097/yco.0b013e328017f6c4

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Malik, P.
Venue
Current Opinion in Psychiatry
Published
2007-03
Volume
20
Issue
2
Pages
138-142
ISSN
0951-7367 (ISSN-L)
OpenAlex
W1992459633
Cited by
54
References
22
Citations by year
2026: 1 · 2025: 2 · 2024: 1 · 2023: 3 · 2022: 1 · 2021: 1 · 2020: 1 · 2019: 5 · 2018: 2 · 2017: 4 · 2016: 2 · 2015: 1 · 2014: 2 · 2013: 2 · 2012: 4
FWCI
3.02
Type
journal article
Language
en
Open access
closed
Locations
  • Current Opinion in Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
  • Health Sciences › Medicine › Psychiatry and Mental health › Sexual function and dysfunction studies
  • Social Sciences › Psychology › Clinical Psychology › Sexuality, Behavior, and Technology
Keywords
sexual dysfunction, schizophrenia, antipsychotic adverse effects, atypical antipsychotics, prolactin elevation, amisulpride, risperidone, quality of life, treatment options
MeSH terms
Cross-Sectional Studies, Female, Humans, Erectile Dysfunction, Libido, Male, Orgasm, Product Surveillance, Postmarketing, Risk Factors, Schizophrenia, Sexual Dysfunction, Physiological, Antipsychotic Agents, Comorbidity

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review